David Rhew’s career has been defined by marrying tech and medicine.

Brittany Holloway-Brown
David Rhew has been working with health AI long before it was cool.
Rhew is an infectious disease physician by training who currently serves as Microsoft’s global chief medical officer and VP of health and life sciences. He did his undergraduate thesis on AI in healthcare at the University of Michigan in the late 1980s, decades before AI became a topic on every health company’s earnings call.
“I remember my advisor calling this very fascinating but kind of hard to believe that this could actually ever happen because we didn’t even have internet then,” Rhew told Healthcare Brew.
Today, Microsoft has a comprehensive healthcare strategy in which AI plays a dominant role. Chairman and CEO Satya Nadella said in a 2021 statement that “AI is technology’s most important priority, and healthcare is its most urgent application.”
Rhew has been a leader of Microsoft’s healthcare strategy since 2019. But it wasn’t a straightforward journey for him to get there.
Rhew describes his career as “the hobbit’s unexpected journey,” a nod to Peter Jackson’s 2012 film, because of his unconventional path from medicine to Big Tech.
Early in his career, as he moved from medical school into residency, Rhew said he was struck by variations in the quality of care he witnessed across different hospitals.
“The more I started looking into it, the more I realized that [quality of care] is actually not only highly variable between the physicians and hospitals, but a large part of it was unwarranted,” he said.
“This was my first introduction in terms of not only technology in healthcare, but then also how this would impact entire industries,” he said.
He now holds six patents for EHR technologies.
From there, Rhew started experimenting to see if information that was being digitized into EHRs could be combined with data from outside healthcare systems, like metrics from wearables and consumer health apps. He joined Samsung Electronics America’s healthcare division in 2013 and spent six years there working toward that goal, though he said he struggled due to a lack of interoperability.
Microsoft then brought him over in 2019 to figure out how to combine EHR and wearable data and enable both its cloud technology and AI “to become a big part of healthcare technology,” he said.
Another part of Rhew’s work at Microsoft involves partnering with health systems to develop AI tools.
In June, Microsoft announced a partnership with the Mayo Clinic in Rochester, Minnesota, to create foundation AI models, which the two organizations said in a press release will use clinical data to “support earlier diagnoses, more personalized treatment decisions, and better patient outcomes.” The partnership is “extremely exciting,” Rhew said, because Mayo “has spent decades building a very robust data infrastructure” that’s ripe for AI.
Microsoft has a similar partnership with Providence, a nonprofit health system based in Renton, Washington, and together they created GigaTIME, an AI pathology model, in 2025. The health system has used the model to analyze how immune cells interact with malignant tumors in hopes of improving cancer treatments.
GigaTIME allowed the health system to identify more than 1,200 “statistically significant associations linking proteins, biomarkers, staging, and survival” across 24 different cancer types, according to a January study.
“It’s not like Microsoft’s coming in and saying, ‘Hey, we’re building [this AI] for ourselves,’” Rhew said. “We’re providing the technologies and the capabilities so that [our partners] can do what is necessary, and then we’re allowing them to be able to figure out how they want to deploy it.”
Matthew Lungren, chief data and AI officer at health tech startup Oku Health, previously worked with Rhew as chief scientific officer for Microsoft health and life sciences. Working together for five years, Lungren said he found Rhew’s biggest strength to be bringing people from different corners of the healthcare industry together.
For instance, Rhew helped start an initiative in 2024 called the Trustworthy Responsible AI Network, or TRAIN, Lungren said. TRAIN gathered more than 15 health systems and a network of community health organizations from across the country to learn from each other about issues of fairness, equity, bias, and governance in AI.
“It’s still astonishing how many people he got to the table, and there was no financial thing; there were no sales pitches as part of this,” he said. “It’s just the kind of conversation that usually you wait for a government institution or you wait for a society to try to do it. All of those kinds of efforts typically don’t have the industry and academic and health systems in one room.”
While Microsoft had been in the healthcare space before Rhew joined, Lungren said he thinks Rhew’s biggest influence on the company has been helping its leaders see what the healthcare system’s needs really are.
“His ability to translate what are the actual needs and problems and risks and opportunities in the healthcare side—no one had really ever done that before, at least in that way,” he said.